These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1906646)

  • 1. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
    Clark WM; Madden KP; Lyden PD; Zivin JA
    Stroke; 1991 Jul; 22(7):872-6. PubMed ID: 1906646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhagic complications of thrombolytic therapy in experimental stroke.
    Slivka A; Pulsinelli W
    Stroke; 1987; 18(6):1148-56. PubMed ID: 3120360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model.
    Carter LP; Guthkelch AN; Orozco J; Temeltas O
    Stroke; 1992 Jun; 23(6):883-8. PubMed ID: 1595109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke.
    Bednar MM; Quilley J; Russell SR; Fuller SP; Booth C; Howard D; Gross CE
    Neurosurgery; 1996 Aug; 39(2):352-9. PubMed ID: 8832673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
    Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
    Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous aspirin causes a paradoxical attenuation of cerebrovascular thrombolysis.
    Thomas GR; Thibodeaux H; Errett CJ; Bednar MM; Gross CE; Bennett WF
    Stroke; 1995 Jun; 26(6):1039-46. PubMed ID: 7762021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC; Gasche Y
    Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A
    Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
    Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
    von Kummer R; Hacke W
    Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.